HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eugenosedin-A ameliorates hyperlipidemia-induced vascular endothelial dysfunction via inhibition of α1-adrenoceptor/5-HT activity and NADPH oxidase expression.

Abstract
Eugenosedin-A (Eu-A) effects on vascular endothelial dysfunction and oxidative stress in a hyperlipidemic rat model were investigated. Rats were randomly divided into four groups: two control groups and two treatment groups. The control rats received a regular diet or high fat diet (HFD); the treatment rats fed received an HFD with 5 mg/kg Eu-A or atorvastatin for 10 weeks. No changes in serotonin levels were observed in the four groups; norepinephrine levels were enhanced in the HFD group which was attenuated by Eu-A and atorvastatin. In the HFD group, the vascular reactivity was increased by vasoconstrictors (5-nonyloxytryptamine, 5-HT, and phenylephrine) and decreased by an endothelium-dependent vasorelaxant, carbachol. Protein levels of α1-adrenergic receptors (not 5-HT1B/2A), reactive oxygen species (ROS) p47(phox), p67(phox), and gp91(phox), and oxidative damage markers 3-nitrotyrosine (3-NT) and 4-hydroxy-2-nonenal (4-HNE) were increased, but endothelial nitric oxide synthase (eNOS), P-eNOS and vasodilator-stimulated phosphoprotein phosphorylation (P-VASP) were decreased. Catalase and superoxide dismutase (SOD-1 and SOD-2) proteins were increased, but glutathione peroxidase (GPx) was decreased in the aorta. Eu-A and atorvastatin reduced vasoconstrictor-induced aortic contractions that might be related to 5-HT1B/2A and α1-adrenergic receptors inhibitory activities. Eu-A and atorvastatin improved eNOS/P-eNOS, P-VASP, GPx, and malondialdehyde (MDA) levels, and decreased ROS and oxidative damage markers. Taken together, we suggest that Eu-A can ameliorate hyperlipidemia-induced vascular endothelial dysfunction and oxidative dysregulation.
AuthorsKuo-Ping Shen, Hui-Li Lin, Wen-Tsan Chang, Jou-Chun Lin, Li-Mei An, Ing-Jun Chen, Bin-Nan Wu
JournalThe Kaohsiung journal of medical sciences (Kaohsiung J Med Sci) Vol. 30 Issue 3 Pg. 116-24 (Mar 2014) ISSN: 2410-8650 [Electronic] China (Republic : 1949- )
PMID24581211 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013. Published by Elsevier B.V.
Chemical References
  • Cell Adhesion Molecules
  • Microfilament Proteins
  • Phosphoproteins
  • Piperazines
  • Reactive Oxygen Species
  • Receptors, Adrenergic
  • eugenosedin-A
  • vasodilator-stimulated phosphoprotein
  • Serotonin
  • Malondialdehyde
  • Superoxide Dismutase
  • NADPH Oxidases
  • Norepinephrine
Topics
  • Animals
  • Aorta, Thoracic
  • Brain (drug effects, metabolism)
  • Cell Adhesion Molecules (metabolism)
  • Endothelium, Vascular (drug effects, metabolism)
  • Hyperlipidemias (complications)
  • Male
  • Malondialdehyde (metabolism)
  • Microfilament Proteins (metabolism)
  • NADPH Oxidases (metabolism)
  • Norepinephrine (blood)
  • Oxidative Stress (drug effects)
  • Phosphoproteins (metabolism)
  • Phosphorylation (drug effects)
  • Piperazines (pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species (metabolism)
  • Receptors, Adrenergic (metabolism)
  • Serotonin (blood, metabolism)
  • Superoxide Dismutase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: